Augmentation of arterial endothelial cell expression of the plasminogen activator inhibitor type-1 (PAI-1) gene by proinsulin and insulin in vivo

Journal of Molecular and Cellular Cardiology

Volumn 30, Issue 8, 1998, Pages 1535-1543

  Nordt, Thomas K ^b   Sawa, Hirofumi ^a   Fujii, Satoshi ^a   Bode, Christoph ^c   Sobel, Burton E ^a  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^c NONE

Author keywords

Atherosclerosis; Diabetes mellitus; Endothelium; Fibrinolysis; Insulin; Proinsulin; Restenosis

Indexed keywords

INSULIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROINSULIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA; ARTERY ENDOTHELIUM; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GLUCOSE CLAMP TECHNIQUE; HYPERINSULINEMIA; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; NONHUMAN; PRIORITY JOURNAL; RABBIT;

EID: 0032143386     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.1998.0719     Document Type: Article

References (37)

1. ALESSI MC, JUHAN-VAGUE I, KOOISTRA T, DECLERCK PJ, COLLEN D, 1988. Insulin stimulates the synthesis of plasminogen activator inhibitor 1 by the human hepatocellular cell line Hep G2. Thromb Haemost 60: 491-494.
2. ARONSON D, BLOOMGARDEN Z, RAYFIELD EJ, 1996. Potential mechanisms promoting restenosis in diabetic patients. J Am Coll Cardiol 27: 528-535.
3. BAKKER CM, METSELAAR HJ, GROENLAND TN, GOMES MJ, KNOT EAR, HESSELINK EJ, SCHALM SW, STIBBE J, TERPSTRA OT, 1992. Increased tissue-type plasminogen activator activity in orthotopic but not heterotopic liver transplantation: the role of the anhepatic period. Hepatology 16: 404-408.
4. BÅVENHOLM P, PROUDLER A, TORNVALL P, GODSLAND I, LANDOU C, DE FAIRE U, HAMSTEN A, 1995. Insulin, intact and split proinsulin, and coronary artery disease in young men. Circulation 92: 1422-1429.
5. THE BYPASS ANGIOPLASTY REVASCULARIZATION INVESTIGATION (BARI) INVESTIGATORS, 1996. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. N Engl J Med 335: 217-225.
6. CHMIELEWSKA J, WIMAN B, 1986. Determination of tissue plasminogen activator and its "fast" inhibitor in plasma. Clin Chem 32: 482-485.
7. CHOMIKI N, HENRY M, ALESSI MC, ANFOSSO F, JUHAN-VAGUE I, 1994. Plasminogen activator inhibitor-1 expression in human liver and healthy or atherosclerotic vessel walls. Thromb Haemostas 72: 44-53.
8. CHRIST G, SEIFFERT D, HUFNAGL P, GESSL A, WOJTA J, BINDER BR, 1993. Type 1 plasminogen activator inhibitor synthesis of endothelial cells is downregulated by smooth muscle cells. Blood 81: 1277-1283.
9. DESPRÉS JP, LAMARCHE B, MAURIÈGE P, CANTIN B, DAGENAIS GR, MOORJANI S, LUPIEN PJ, 1996. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med 334: 952-957.
10. FUJII S, SAWA H, SAFFITZ JE, LUCORE CL, SOBEL BE, 1992. Induction of endothelial cell expression of the plasminogen activator inhibitor type 1 gene by thrombosis in vivo. Circulation 86: 2000-2010.
11. GALLICCHIO M, ARGYRIOU S, IANCHES G, FILONZI EL, ZOELLNER H, HAMILTON JA, MCGRATH K, WOJTA J, 1994. Stimulation of PAI-1 expression in endothelial cells by cultured vascular smooth muscle cells. Arterioscler Thromb 14: 815-823.
12. HAMSTEN A, 1993. The hemostatic system and coronary heart disease. Thromb Res 70: 1-38.
13. HOWARD G, O'LEARY DH, ZACCARO D, HAFFNER S, REWERS M, HAMMAN R, SELBY JV, SAAD MF, SAVAGE P, BERGMAN R, FOR THE IRAS INVESTIGATORS, 1996. Insulin sensitivity and atherosclerosis. Circulation 93: 1809-1817.
14. JUHAN-VAGUE I, ALESSI MC, VAGUE P, 1991. Increased plasma plasminogen activator inhibitor 1 levels. A possible link between insulin resistance and atherothrombosis. Diabetologia 34: 457-462.
15. KANNEL WB, MCGEE DL, 1979. Diabetes and cardiovascular disease: the Framingham study. JAMA 241: 2035-2038.
16. KLASSEN KJ, NORDT TK, SCHNEIDER DJ, SOBEL BE, 1993. Constitutive biosynthesis of plasminogen activator inhibitor type-1 (PAI-1) by cultured human aortic endothelial cells independent of insulin. Coronary Artery Disease 4: 713-719.
17. LUPU F, BERGONZELLI GE, HEIM DA, COUSIN E, GENTON CY, BACHMANN F, KRUITHOF EKO, 1993. Localization and production of plasminogen activator inhibitor-1 in human healthy and atherosclerotic arteries. Arterioscler Thromb 13: 1090-1100.
18. NORDT TK, KLASSEN KJ, SCHNEIDER DJ, SOBEL BE, 1993. Augmentation of synthesis of plasminogen activator inhibitor type-1 in arterial endothelial cells by glucose and its implications for local fibrinolysis. Arterioscler Thromb 13: 1822-1828.
19. NORDT TK, SCHNEIDER DJ, SOBEL BE, 1994. Augmentation of the synthesis of plasminogen activator inhibitor type-1 by precursors of insulin: a potential risk factor for vascular disease. Circulation 89: 321-330.
20. NORDT TK, SAWA H, FUJII S, SOBEL BE, 1995. Induction of plasminogen activator inhibitor type-1 (PAI-1) by proinsulin and insulin in vivo. Circulation 91: 764-770.
21. PADRÓ T, EMEIS JJ, STEINS M, SCHMID KW, KIENAST J, 1995. Quantification of plasminogen activators and their inhibitors in the aortic vessel wall in relation to the presence and severity of atherosclerotic disease. Arterioscler Thromb Vasc Biol 15: 893-902.
22. RAGHUNATH PN, TOMASZEWSKI JE, BRADY ST, CARON RJ, OKADA SS, BARNATHAN ES, 1995. Plasminogen activator system in human coronary atherosclerosis. Arterioscler Thromb Vasc Biol 15: 1432-1443.
23. SAWA H, FUJII S, SOBEL BE, 1992. Augmented arterial wall expression of type-1 plasminogen activator inhibitor induced by thrombosis. Arterioscler Thromb 12: 1507-1515.
24. SCHATZ H, AMMERMANN S, LAUBE H, FEDERLIN K, 1988. Bioactivity and pharmakokinetic of human proinsulin in comparison to human insulin after intravenous and subcutaneous injection. Harm Metabol Res 20: 445-449.
25. SCHNEIDER DJ, SOBEL BE, 1991. Augmentation of synthesis of plasminogen activator inhibitor type 1 by insulin and insulin-like growth factor type I: implications for vascular disease in hyperinsulinemic states. Proc Natl Acad Sci USA 88: 9959-9963.
26. SCHNEIDER DJ, NORDT TK, SOBEL BE, 1992. Stimulation by proinsulin of expression of plasminogen activator inhibitor type-1 in endothelial cells. Diabetes 41: 890-895.
27. SCHNEIDER DJ, ABSHER PM, RICCI MA, (1997). Dependence of augmentation of arterial endothelial cell expression of plasminogen activator inhibitor type 1 by insulin on soluble factors released from vascular smooth muscle cells. Circulation 96: 2868-2876.
28. SCHNEIDERMAN J, SAWDEY MS, KEETON MR, BORDIN GM, BERNSTEIN EF, DILLEY RB, LOSKUTOFF DJ, 1992. Increased type 1 plasminogen activator inhibitor gene expression in atherosclerotic human arteries. Proc Natl Acad Sci USA 89: 6998-7002.
29. SIMMONS DM, ARRIZA JL, SWANSON LW, 1989. A complete protocol for in situ hybridization of messenger RNAs in brain and other tissues with radio-labeled single-stranded RNA probes. J Histotechnol 12: 169-181.
30. SIMPSON AJ, BOOTH NA, MOORE NR, BENNETT B, 1991. Distribution of plasminogen activator inhibitor (PAI-1) in tissues. J Clin Pathol 44: 139-143.
31. SOBEL BE, 1996. Potentiation of vasculopathy by insulin. Implications from an NHLBI clinical alert. Circulation 93: 1613-1615.
32. TEMPLE RC, CLARK PMS, NAGI DK, SCHNEIDER AE, YUDKIN JS, HALES CN, 1990. Radioimmunoassay may overestimate insulin in non-insulin-dependent diabetics. Clin Endocrinol 32: 689-693.
33. THORNTON AJ, GELEHRTER TD, 1995. Human hepatocytes express the gene for type 1 plasminogen activator inhibitor (PAI-1) in vivo. Fibrinolysis 9: 9-15.
34. VARAGONA G, BROWN D, HAASE A, DUSHEIKO G, 1992. Increased steady-state levels of alpha-fetoprotein mRNA in hepatocellular carcinoma: an analysis by in situ hybridization. Liver 12: 62-68.
35. WARD WK, LACAVA EC, PAQUETTE TL, BEARD JC, WALLUM BJ, PORTE D, 1987. Disproportionate elevation of immunoreactive proinsulin in type 2 (non-insulin-dependent) diabetes mellitus and in experimental insulin resistance. Diabetologia 30: 698-702.
36. WEINTRAUB WS, GHAZZAL ZMB, DOUGLAS JR. JS, LIBERMAN H, MORRIS DC, COHEN CL, KING III SB, 1992. Initial management and long-term clinical outcome of restenosis after initially successful percutaneous transluminal coronary angioplasty. Am J Cardiol 70: 47-55.
37. YAMAMOTO K, LOSKUTOFF DJ, 1996. Fibrin deposition in tissues from endotoxin-treated mice correlates with decreases in the expression of urokinase-type but not tissue-type plasminogen activator. J Clin Invest 97: 2440-2451.